A Study of the Pharmacokinetics and Pharmacodynamics of MK1809 (1809-001)(COMPLETED)
Status:
Completed
Trial end date:
2008-06-19
Target enrollment:
Participant gender:
Summary
The goal of this study is to identify at least one safe and well tolerated dose of MK1809
that has similar pharmacokinetic qualities as 100 mg losartan.